Not approved (research only)Short bioregulator peptideLiver research
Livagen
Livagen is a short synthetic peptide from the bioregulator research tradition with very limited published human data.
What is Livagen?
Livagen is a short synthetic peptide from the bioregulator research tradition with very limited published human data. Livagen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Key takeaways
- Livagen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
- PubMed indexes 18 papers on Livagen (0 tagged as clinical trials) as of October 19, 2026.
- 10 vendors in our directory listed Livagen in their public catalog on October 19, 2026.
Structure
Regulatory & access status
Livagen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.
How much research exists on Livagen?
PubMed indexes 18 papers mentioning Livagen in the title or abstract, 1 of them from the last five years and 0 tagged as clinical trials (search run October 19, 2026; repeat the search).
Most relevant recent papers
- Effects of Livagen peptide on chromatin activation in lymphocytes from old people. — Bull Exp Biol Med, 2002
- [Genomic instability in atherosclerosis]. — Georgian Med News, 2014
- Activation of pericentromeric and telomeric heterochromatin in cultured lymphocytes from old individuals. — Ann N Y Acad Sci, 2007
- Effects of short peptides on lymphocyte chromatin in senile subjects. — Bull Exp Biol Med, 2004
- [Effect of peptide Livagen on activity of digestive enzymes in gastrointestinal tract and non-digestive organs in rats of different ages]. — Adv Gerontol, 2005
- [Effect of peptide bioregulator and cobalt ions on the activity of NORs and associations of acrocentric chromosomes in lymphocytes of patients with hypertrophic cardiomyopathy and their relatives]. — Georgian Med News, 2014
What the evidence does not show
- Paper counts measure research attention, not whether Livagen works or is safe.
- No clinical trial in humans is tagged in PubMed under this name.
- No FDA review of any "research use only" product's identity, purity, sterility or dose.
Research suppliers that list Livagen
10 vendors in our directory listed a product matching Livagen in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.
- BioLongevity Labs
- Biotech Peptides
- Bulk Peptide Supply
- Core Peptides
- Eros Peptides
- Modern Aminos
- NuScience Peptides
- Pure Lab Peptides
- Swiss Chems
- Xcel Peptides
Prices per mg, where we could verify them, are on our price comparison.
Livagen reconstitution math
Lab arithmetic only, not dosing guidance: use the peptide calculator to turn a vial size and diluent volume into a concentration.
Livagen FAQ
Is Livagen FDA-approved?
Livagen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Is Livagen safe?
There are no published human safety trials of Livagen that we could find. Products sold as "research use only" have no FDA review of purity, sterility or dose, and are not for human use.
How much research is there on Livagen?
PubMed indexes 18 papers on Livagen (0 tagged as clinical trials) as of October 19, 2026.
Who sells Livagen?
BioLongevity Labs, Biotech Peptides, Bulk Peptide Supply, Core Peptides, Eros Peptides, Modern Aminos and 4 more listed it on their public catalogs when we checked; a listing is not an endorsement.
Related compounds
TRHMelanotan IPNC-27OvagenAOD-9604 + CJC-1295 + ipamorelin blendCardiogenCortagenSLU-PP-332All bioregulators & other research compounds